Advertisement
Product › Details
cancer immunotherapy_o
Next higher product group | cancer immunotherapy (immuno-oncology, I-O) | |
Status | 2012-10-06 | |
Record changed: 2023-07-10 |
Advertisement
More documents for cancer immunotherapy_o
- [1] Affimed N.V.. (3/6/24). "Press Release: Affimed Announces 1-for-10 Reverse Stock Split". Mannheim....
- [2] Affimed N.V.. (11/1/22). "Press Release: Affimed to Present at the 2022 Jefferies London Healthcare Conference". Heidelberg....
- [3] Affimed N.V.. (4/13/22). "Press Release: Affimed Announces Pricing of Upsized $90 Million Public Offering of Common Shares". Heidelberg....
- [4] Affimed N.V.. (4/12/22). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg....
- [5] Affimed N.V.. (6/16/21). "Press Release: Affimed Announces Appointment of Uta Kemmerich-Keil to its Supervisory Board". Heidelberg....
- [6] Affimed N.V.. (1/15/21). "Press Release: Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Heidelberg....
- [7] Affimed N.V.. (1/12/21). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg....
- [8] Affimed N.V.. (1/12/21). "Press Release: Affimed Announces Pricing of $100,000,000 Public Offering of Common Shares". Heidelberg....
- [9] Affimed N.V.. (8/5/20). "Press Release: Affimed Announces Two New Appointments to Its Supervisory Board". Heidelberg....
- [10] Affimed N.V.. (6/11/20). "Press Release: Affimed Announces Appointment of Angus Smith as Chief Financial Officer". Heidelberg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top